Research and analysis

COVID-19 vaccine weekly surveillance reports (weeks 39 to 49)50)

Data on the real-world effectiveness and impact of the COVID-19 vaccines.

From:
UK Health Security Agency
Published
30 September 2021
Last updated
916 December 2021 — See all updates

Applies to England

Documents

COVID-19 vaccine surveillance report: 16 December 2021 (week 50)

Ref: UKHSA gateway number GOV-10787 PDF, 4.4 MB, 52 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 9 December 2021 (week 49)

Ref: UKHSA publications gateway number GOV-10685 PDF, 1.4 MB, 49 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 2 December 2021 (week 48)

Ref: UKHSA gateway number GOV-10603 PDF, 5.44 MB, 47 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 25 November 2021 (week 47)

PDF, 880 KB, 46 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 18 November 2021 (week 46)

Ref: UKHSA gateway number GOV-10461 PDF, 3.19 MB, 35 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 11 November 2021 (week 45)

Ref: UKHSA gateway number GOV-10390 PDF, 1.09 MB, 34 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 4 November 2021 (week 44)

Ref: UKHSA gateway number GOV-10335 PDF, 642 KB, 32 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 28 October 2021 (week 43)

Ref: UKHSA gateway number GOV-10290 PDF, 886 KB, 31 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 21 October 2021 (week 42)

Ref: UKHSA gateway number GOV-10227 PDF, 565 KB, 29 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 14 October 2021 (week 41)

Ref: UKHSA gateway number GOV-10158 PDF, 624 KB, 27 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 7 October 2021 (week 40)

Ref: UKHSA gateway number GOV-10076 PDF, 618 KB, 27 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 30 September 2021 (week 39)

Ref: UKHSA gateway number GOV-9995 PDF, 965 KB, 34 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

UK Health Security Agency (UKHSA) is monitoring the effectiveness of the vaccines in the real world as set out in the COVID-19 vaccine surveillance strategy and the impact on:

  • symptomatic disease
  • hospitalisation
  • death
  • infection (symptomatic or asymptomatic)
  • transmission

Reports for weeks 19 to 38 are available and earlier weekly reports are available as part of the National flu and COVID-19 surveillance reports.

Further reports on monitoring of the effectiveness of COVID-19 vaccination have been published.

Published 30 September 2021
Last updated 916 December 2021 + show all updates

  2. Added COVID-19 vaccine surveillance report: 9 December 2021 (week 49).

  3. Added COVID-19 vaccine surveillance report: 2 December 2021 (week 48).

  4. Added COVID-19 vaccine surveillance report: 25 November 2021 (week 47).

  7. Added COVID-19 vaccine surveillance report: 4 November 2021 (week 44).

  8. Added COVID-19 vaccine surveillance report: 28 October 2021 (week 43).

  9. Added COVID-19 vaccine surveillance report: 21 October 2021 (week 42).

  10. Added COVID-19 vaccine surveillance report: 14 October 2021 (week 41).